Skip to main content
Equibles

Nuveen, LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1871926 CHARLOTTE, NC
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$21,874,322
+$620,047 QoQ
Shares Held
834,261
-7.5% QoQ
Ownership
0.664%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 271 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Nuveen, LLC holds $4,966,990,470 across 286 Biotechnology names. ARQT ranks #51 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,019,974 $1,259,534,587
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,081,685 $537,305,388
3 EXEL
Exelixis, Inc.
 3,276,984 $178,300,697
4 ALNY
Alnylam Pharmaceuticals, Inc.
 315,630 $95,014,096
5 TGTX
Tg Therapeutics, Inc.
 1,625,876 $89,325,625
6 RVMD
Revolution Medicines, Inc.
 475,231 $89,001,259
7 JAZZ
Jazz Pharmaceuticals plc
 365,405 $88,051,641
8 ROIV
Roivant Sciences Ltd.
 1,970,504 $69,736,134

All Filings in ARQT

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,874,322 834,261
2026-03-31 $21,254,275 902,134
2025-12-31 $40,137,925 1,382,160
2025-09-30 $25,831,209 1,370,356
2025-06-30 $10,733,415 765,579
2025-03-31 $12,759,361 815,816